(Q33822681)

English

Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Epstein–Barr virus

0 references

Dewi Kartikawati Paramita

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jaap M Middeldorp

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

5

object named as

Jajah Fachiroh

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

6

object named as

Sofia M Haryana

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Christien Fatmawati

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hedy Juwana

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Frank G van Schaijk

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Journal of Medical Virology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

83

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

665-678

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21328382%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for fie

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Characterization of the antibody response to the latent infection terminal proteins of Epstein-Barr virus in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Antibodies to LMP2A/2B in EBV-carrying malignancies.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Bioreactor-scale production and one-step purification of Epstein-Barr nuclear antigen 1 expressed in baculovirus-infected insect cells.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Epitope-mapping on the Epstein-Barr virus major capsid protein using systematic synthesis of overlapping oligopeptides

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Screening for family members of patients with nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Epstein-Barr virus: evasive maneuvers in the development of PTLD.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Epstein-Barr virus: exploiting the immune system

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21960

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33822681&oldid=1976381621"